Immunetics, Inc. brings advanced immunoassay technology to the diagnosis of
infectious diseases, with third generation ELISA and Western Blot kits. In
an era of acute and emerging infectious diseases, our products are at the
front lines of healthcare. We aim to make a difference for patients
worldwide with life threatening viral, bacterial and parasitic infections.
Our line of clinical diagnostic and research products includes QualiCode(tm)
Western Blot kits for tick-borne, viral and parasitic diseases and the C6 B.
burgdorferi (Lyme) ELISA, internationally recognized as the new performance
standard in Lyme testing. In the growing field of biodefense, Immunetics
offers the first FDA-approved ELISA kit for detection of anthrax infection.
We also offer patented Miniblotter® instruments for blotting, spoligotyping
and other membrane assays. Immunetics has received numerous NIH grants for
development of assays and instrumentation, and collaborates actively with
researchers worldwide to transform cutting edge technology into new products
for clinical diagnostics and research applications. Our mission is better,
cost-efficient care through more accurate diagnosis.